Display options
Cite
Belpomme D, Irigaray P. Replicative random mutations as an unproven cause of cancer: A technical comment. Mol Clin Oncol. 2016;4(4):497-499doi: 10.3892/mco.2016.737.
Belpomme, D., & Irigaray, P. (2016). Replicative random mutations as an unproven cause of cancer: A technical comment. Molecular and clinical oncology, 4(4), 497-499. https://doi.org/10.3892/mco.2016.737
Belpomme, Dominique, and Irigaray, Philippe. "Replicative random mutations as an unproven cause of cancer: A technical comment." Molecular and clinical oncology vol. 4,4 (2016): 497-499. doi: https://doi.org/10.3892/mco.2016.737
Belpomme D, Irigaray P. Replicative random mutations as an unproven cause of cancer: A technical comment. Mol Clin Oncol. 2016 Apr;4(4):497-499. doi: 10.3892/mco.2016.737. Epub 2016 Jan 25. PMID: 27073649; PMCID: PMC4812174.
Copy Download .nbib Format: NLM
Share it on

Mol Clin Oncol. 2016 Apr;4(4):497-499. doi: 10.3892/mco.2016.737. Epub 2016 Jan 25.

Replicative random mutations as an unproven cause of cancer: A technical comment.

Molecular and clinical oncology

Dominique Belpomme, Philippe Irigaray

Affiliations

  1. Cancer Research Center, Association for Research and Treatments Against Cancer (ARTAC), F-75015 Paris, France; European Cancer and Environment Research Institute (ECERI), B-1000 Brussels, Belgium.

PMID: 27073649 PMCID: PMC4812174 DOI: 10.3892/mco.2016.737

Abstract

A careful molecular biology, epidemiological and mathematical modelling reanalysis of the recently published study titled 'Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions' by Cristian Tomasetti and Bert Vogelstein, which was published on January 2, 2015 in the distinguished journal Science, led to the conclusion that, contrary to the authors' claim, many cancer types are not caused by replicative random mutations. Rather than the authors' two arbitrarily individualized groups of cancer, a three-group model is herein proposed in the framework of this technical comment, considerably reducing the fraction of cancer cases hypothetically attributable to random mutations.

Keywords: cancer; carcinogenesis; environment; epidemiology; mutagens; mutations

References

  1. Nat Rev Cancer. 2014 Apr;14 (4):277-89 - PubMed
  2. Environ Res. 2007 Nov;105(3):414-29 - PubMed
  3. Science. 1991 Jan 25;251(4992):387-8 - PubMed
  4. Science. 2015 Feb 13;347(6223):728-9 - PubMed
  5. Science. 2015 Feb 13;347(6223):727 - PubMed
  6. Science. 2015 Feb 13;347(6223):728 - PubMed
  7. Int J Oncol. 2007 May;30(5):1037-49 - PubMed
  8. Science. 2015 Jan 2;347(6217):78-81 - PubMed
  9. Science. 2015 Feb 13;347(6223):729-31 - PubMed
  10. Carcinogenesis. 2010 Feb;31(2):135-48 - PubMed
  11. Toxicol Pathol. 2014 Jan;42(1):12-44 - PubMed
  12. Nature. 2007 Mar 8;446(7132):153-8 - PubMed
  13. J Natl Cancer Inst. 2004 Jul 21;96(14):1050-1 - PubMed
  14. Genetics. 1998 Apr;148(4):1667-86 - PubMed
  15. Science. 2006 Oct 13;314(5797):268-74 - PubMed
  16. Science. 2015 Feb 13;347(6223):728 - PubMed
  17. Science. 2015 Feb 13;347(6223):729 - PubMed
  18. Science. 2015 Feb 13;347(6223):727 - PubMed
  19. Science. 2015 Jan 2;347(6217):12 - PubMed
  20. Trends Endocrinol Metab. 2010 Apr;21(4):214-22 - PubMed
  21. Science. 2012 Mar 9;335(6073):1235-8 - PubMed

Publication Types